Tag: Business Standard
After Covishield, Covaxin under the radar
A study conducted by researchers at Banaras Hindu University (BHU) says a third of the surveyed individuals who received Bharat Biotech’s Covid-19 vaccine Covaxin...
Bharat Biotech’s nasal Covid vaccine to roll out in January
Bharat Biotech’s intranasal Covid-19 vaccine – the iNCOVACC (BBV154) – will be sold for ₹325 per dose at government hospitals, and for ₹800 in...
Orchid Pharma set to commercialize molecule that treats acute UTI
From a debt-ridden company to making a turnaround and now raking in profits, Orchid Pharma is a story worth emulating.
Taken over by the Dhanuka...
Suven begins phase 3 trial for Alzheimer’s drug
Hyderabad-based Suven Life Sciences, which provides drug discovery and development support services to global pharma and biotech companies, has begun phase 3 trials for...
Boehringer Ingelheim bans four Indian pharma firms
Multinational pharmaceutical giant Boehringer Ingelheim has acquired ad-interim injunctions against four Indian pharmaceutical companies. These companies had dispatched generic versions of a patent-protected drug...
Antiviral medications might lower Monkeypox symptoms
Lancet’s study shows some antiviral medications could curtail monkeypox symptoms. It can even shorten the contagion period of the viral disease. The study reports...
White House announces first Covid vaccine for young kids
Aashish Jha, the White House Covid-19 coordinator, declared about the government’s plan for vaccinating the population for kids below 5 years. The waiting time...
Serum Institute to launch vaccine for cervical cancer
The Serum Institute of India (SII) has asked for approval from the government to produce the quadrivalent human papillomavirus vaccine to fight cervical cancer....
Covid-19 may lead to Parkinson’s disease
As per the US study, Covid-19 is associated with the chance of developing Parkinson’s disease. This new finding is based on past evidence that...
Genomic sequencing – A huge problem in Bihar and UP
Bihar and Uttar Pradesh are particularly affected by genome sequencing programs. These states are the least in charge of the Covid-19 protocols.
According to a...